Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dovramilast by Medicines Development for Global Health for Tuberculosis: Likelihood of Approval
Dovramilast is under clinical development by Medicines Development for Global Health and currently in Phase II for Tuberculosis. According to...